Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.72
+0.07000.25%
Post-market: 27.730.0123+0.04%19:59 EDT
Volume:25.56M
Turnover:705.42M
Market Cap:157.61B
PE:36.48
High:27.85
Open:27.80
Low:27.42
Close:27.65
52wk High:29.21
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.91
T/O Rate:0.45%
Dividend:1.72
Dividend Rate:6.20%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.85
PE(LYR):20.32

Loading ...

Pfizer - Litfulo Phase 3 Studies Meet Co-Primary Endpoints at Week 52 in Vitiligo

THOMSON REUTERS
·
Jul 30

New York City has paused construction at several office-to-apartment conversions since Pfizer tower structural problems

CNN Business
·
Jul 30

NYC Officials Halt Construction at Third Manhattan Conversion Project

Dow Jones
·
Jul 30

BioNTech and Pfizer Secure EU Approval for XFG-Adapted COVID-19 Vaccine for 2026-2027 Season

TIPRANKS
·
Jul 30

Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval

Dow Jones
·
Jul 30

EU Authorizes Pfizer-BioNTech XFG-adapted COVID Vaccine for Ages 6 Months and Up

Reuters
·
Jul 30

Pfizer - Shipping of Xfg-Adapted Covid-19 Vaccine to Begin Soon

THOMSON REUTERS
·
Jul 30

Earning Preview: Pfizer this quarter’s revenue is expected to increase by 6.35%, and institutional views are cautious

Earnings Agent
·
Jul 29

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Movement Alert|Pfizer Rises 3.08% in Regular Trading, Pharma Sector Broadly Lifted by GlaxoSmithKline Strong Q2 Earnings

Market Focus
·
Jul 28

Pfizer: Hold Rating Reiterated as Analyst Keeps $28 Price Target Unchanged Amid Balanced Pipeline Prospects and LOE Headwinds

TIPRANKS
·
Jul 28

Pfizer Ltd June-Quarter Net Profit 2.04 Billion Rupees

Reuters
·
Jul 28

Pfizer’s Bold Pipeline Bets Aim to Revive PFE

TIPRANKS
·
Jul 25

Pfizer’s PF-08057418 Clears Phase 1 Safety Milestone, Offering a Quiet Boost to Pipeline Confidence

TIPRANKS
·
Jul 25

How Investors May Respond To Pfizer (PFE) Prostate Cancer Combo Drug Label Expansion Push

Simply Wall St.
·
Jul 24

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Healthcare Services (HCSG)

TIPRANKS
·
Jul 23

NYSE Most Active Issues

Dow Jones
·
Jul 23

Pfizer's Talzenna-xtandi Combo Gets FDA Priority Review for Earlier-stage Prostate Cancer

Dow Jones
·
Jul 23

Pfizer's Prostate Cancer Drug Combination Gets FDA Priority Review

Reuters
·
Jul 23

FDA Grants Priority Review for Pfizer’s Talzenna Plus Xtandi for the Treatment of Metastatic Prostate Cancer

THOMSON REUTERS
·
Jul 23